{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:37:17Z","timestamp":1793752637690,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ygyno.2005.06.028","type":"journal-article","created":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T20:00:22Z","timestamp":1122580822000},"page":"393-399","source":"Crossref","is-referenced-by-count":109,"title":["Rapid inpatient\/outpatient desensitization for chemotherapy hypersensitivity: Standard protocol effective in 57 patients for 255 courses"],"prefix":"10.1016","volume":"99","author":[{"given":"Chyh-Woei","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula A.","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.06.028_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1006\/gyno.2001.6331","article-title":"Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies","volume":"82","author":"Robinson","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin\u2013paclitaxel versus cisplatin\u2013cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2005.06.028_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","article-title":"Primary ovarian cancer chemotherapy: current standards of care","volume":"89","author":"McGuire","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.06.028_bib4","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","article-title":"Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy","volume":"19","author":"Zanotti","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2000.18.1.102","article-title":"Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center","volume":"18","author":"Markman","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1081-1206(10)61465-2","article-title":"Carboplatin desensitization","volume":"93","author":"Choi","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0091-6749(96)70134-3","article-title":"A modified, prolonged desensitization protocol in carboplatin allergy","volume":"98","author":"Goldberg","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00432-003-0501-3","article-title":"Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions","volume":"130","author":"Markman","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0959-8049(94)90489-8","article-title":"Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma","volume":"30A","author":"Morgan","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.06.028_bib11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaci.2004.05.061","article-title":"Safety and efficacy of repeated monthly carboplatin desensitization","volume":"114","author":"Morgan","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1200\/JCO.1993.11.5.885","article-title":"Successful re-treatment with taxol after major hypersensitivity reactions","volume":"11","author":"Peereboom","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0090-8258(03)00178-1","article-title":"Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity","volume":"89","author":"Rose","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0091-6749(92)90142-O","article-title":"Anaphylaxis to carboplatin\u2014A new platinum chemotherapeutic agent","volume":"90","author":"Windom","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0091-6749(96)70281-6","article-title":"Successful parenteral desensitization to paclitaxel","volume":"97","author":"Essayan","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/gyno.1997.4906","article-title":"Taxol hypersensitivity: rapid retreatment is safe and cost effective","volume":"68","author":"Olson","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ygyno.2004.11.043","article-title":"Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments","volume":"96","author":"Feldweg","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib20","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2003.05.539","article-title":"Expanded experience with an intradermal skin test to predict for the presence or absence of Carboplatin hypersensitivity","volume":"21","author":"Markman","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)61136-2","article-title":"Antigen-IgE desensitization of mast cells by suboptimal antigen is abrogated in signal transducer and activator of transcription (STAT) 6 deficient mast cells","volume":"94","author":"Morales","year":"2005","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib22","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.06.028_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1567-5769(01)00006-6","article-title":"Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions","volume":"1","author":"Szebeni","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib24","first-page":"374","article-title":"Taxol enhances but does not induce interleukin-1 beta and tumor necrosis factor-alpha production","volume":"122","author":"Allen","year":"1993","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ygyno.2005.06.028_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.1970196","article-title":"Shared actions of endotoxin and taxol on TNF receptors and TNF release","volume":"248","author":"Ding","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2005.06.028_bib26","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.4049\/jimmunol.162.11.6811","article-title":"Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide","volume":"162","author":"Mullins","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.166.1.574","article-title":"CD11b\/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression","volume":"166","author":"Perera","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.1994.1098","article-title":"Death from anaphylaxis to cisplatin: a case report","volume":"53","author":"Zweizig","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.06.028_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/gyno.2001.6519","article-title":"Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy","volume":"84","author":"Dizon","year":"2002","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805004567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805004567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T05:45:21Z","timestamp":1706420721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805004567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0090825805004567"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.06.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}